NASDAQ:AFYA

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Unidompedro and Faculdade Dom Luiz

Retrieved on: 
Thursday, May 2, 2024

The acquisition will add 300 operational medical school seats to Afya in Salvador, one of Brazil's largest cities.

Key Points: 
  • The acquisition will add 300 operational medical school seats to Afya in Salvador, one of Brazil's largest cities.
  • In 2021, as a result of a judicial order, MEC reviewed the Ordinance to authorize the 300 seats initially requested by Unidompedro.
  • The aggregate purchase price is R$ 660.0 million, and the Net Debt will be deducted at closing.
  • Additionally, if Unidompedro or Faculdade Dom Luiz wins the bid processes in the Mais Médicos 3 Program, an additional payment of R$250 thousand per granted seat will be made.

Afya Limited Announces Medical Seats Increase in FIP Guanambi

Retrieved on: 
Wednesday, January 24, 2024

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 40 medical seats of Faculdades Integradas Padrão (FIP Guanambi), in the city of Guanambi, located in the state of Bahia, which will result in an additional payment of R$49,6 million.

Key Points: 
  • Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 40 medical seats of Faculdades Integradas Padrão (FIP Guanambi), in the city of Guanambi, located in the state of Bahia, which will result in an additional payment of R$49,6 million.
  • With the authorization, Afya reaches 100 medical seats on this campus, and 3,203 total approved seats.

Afya Limited Announces Additional Purchase of 15% of Centro de Ciências em Saúde de Itajubá S.A.

Retrieved on: 
Tuesday, October 31, 2023

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced an additional acquisition, through its wholly-owned subsidiary Afya Participações S.A. (“Afya Brazil”), of an additional 15% of Centro de Ciências em Saúde de Itajubá S.A. ("CCSI”;”FMIT”), consolidating our position of ownership to 75% of the total share capital.

Key Points: 
  • Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced an additional acquisition, through its wholly-owned subsidiary Afya Participações S.A. (“Afya Brazil”), of an additional 15% of Centro de Ciências em Saúde de Itajubá S.A. ("CCSI”;”FMIT”), consolidating our position of ownership to 75% of the total share capital.
  • The aggregate purchase price for the additional 15% was R$21.0 million paid 100% in cash on the date hereof.
  • On May 30, 2018, Afya Brazil acquired 60% of FMIT, which has already been fully integrated into Afya’s operation since 2019.
  • FMIT is a post-secondary education institution located in the city of Itajubá, in the state of Minas Gerais.

Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th

Retrieved on: 
Monday, October 2, 2023

Afya Limited, or “Afya” (Nasdaq: AFYA, B3: A2FY34) announced today that will report third-quarter and nine months 2023 financial results for the period ended September 30th, 2023, following the close of the market on Monday, November 13th, 2023 and will host a corresponding conference call and webcast at 05:00 pm EST.

Key Points: 
  • Afya Limited, or “Afya” (Nasdaq: AFYA, B3: A2FY34) announced today that will report third-quarter and nine months 2023 financial results for the period ended September 30th, 2023, following the close of the market on Monday, November 13th, 2023 and will host a corresponding conference call and webcast at 05:00 pm EST.
  • To participate in Afya’s Third Quarter and Nine Months 2023 conference call, please follow the instructions below:
    Brazil: +55 11 4632 2236 or +55 11 4632 2237 or +55 11 4680 6788 or +55 11 4700 9668 or +55 21 3958 7888.
  • United States: +1 929 205 6099 or +1 301 715 8592 or +1 305 224 1968 or +1 309 205 3325 or +1 312 626 6799 or +1 646 931 3860 or +1 346 248 7799 or +1 360 209 5623 or +1 386 347 5053 or +1 507 473 4847 or +1 564 217 2000 or +1 669 444 9171 or +1 669 900 6833 or +1 689 278 1000 or +1 719 359 4580 or +1 253 205 0468 or +1 253 215 8782.

Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28

Retrieved on: 
Tuesday, July 25, 2023

Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT.

Key Points: 
  • Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT.
  • To participate in Afya’s Second Quarter and First Half 2023 conference call, please follow the instructions below:
    Brazil: +55 21 3958 7888 or +55 11 4632 2236 or +55 11 4632 2237 or +55 11 4680 6788 or +55 11 4700 9668.
  • United States: +1 305 224 1968 or +1 309 205 3325 or +1 312 626 6799 or +1 346 248 7799 or +1 360 209 5623 or +1 386 347 5053 or +1 507 473 4847 or +1 564 217 2000 or +1 646 931 3860 or +1 669 444 9171 or +1 669 900 6833 or +1 689 278 1000 or +1 719 359 4580 or +1 929 205 6099 or +1 253 205 0468 or +1 253 215 8782 or +1 301 715 8592.

Afya Announces the Start of Negotiation of Its Non-Sponsored Brazilian Depositary Receipts (BDRs) in B3

Retrieved on: 
Monday, July 24, 2023

Afya Limited, or “Afya” (Nasdaq: AFYA, B3:A2FY), announced today the start of negotiation of its non-sponsored Brazilian Depositary Receipts (BDRs), with a 1-for-2 stock split, aimed to provide investment opportunities on Afya for Brazilian investors.

Key Points: 

Afya Limited, or “Afya” (Nasdaq: AFYA, B3:A2FY), announced today the start of negotiation of its non-sponsored Brazilian Depositary Receipts (BDRs), with a 1-for-2 stock split, aimed to provide investment opportunities on Afya for Brazilian investors.